Filament Health Corp.
FH
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -89.33% | -94.48% | 72.47% | -- | 916.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -89.33% | -94.48% | 72.47% | -- | 916.21% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -89.33% | -94.48% | 72.47% | -- | 916.21% |
| SG&A Expenses | -40.71% | -41.04% | -33.99% | -21.54% | 115.36% |
| Depreciation & Amortization | -1.02% | -0.75% | 2.62% | 5.61% | 4.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -45.77% | -38.98% | -29.12% | -11.12% | 85.78% |
| Operating Income | -31.17% | 22.09% | 33.92% | 38.28% | 23.97% |
| Income Before Tax | -61.76% | 26.70% | 33.51% | 27.42% | 89.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -61.76% | 26.70% | 33.51% | 27.42% | 89.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.76% | 26.70% | 33.51% | 27.42% | 89.86% |
| EBIT | -31.17% | 22.09% | 33.92% | 38.28% | 23.97% |
| EBITDA | -31.77% | 20.00% | 32.76% | 37.15% | 24.48% |
| EPS Basic | -40.00% | 50.00% | 47.69% | 39.62% | 92.17% |
| Normalized Basic EPS | 8.00% | 51.43% | 48.78% | 39.39% | 35.90% |
| EPS Diluted | -40.00% | 50.00% | 47.69% | 39.62% | 92.17% |
| Normalized Diluted EPS | 8.00% | 51.43% | 48.78% | 39.39% | 35.90% |
| Average Basic Shares Outstanding | 15.87% | 46.44% | 25.81% | 20.73% | 29.07% |
| Average Diluted Shares Outstanding | 15.87% | 46.44% | 25.81% | 20.73% | 29.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |